Status:
COMPLETED
Preventive Arterial Wall Phenotype and Low-dose Fluvastatin/Valsartan Combination
Lead Sponsor:
University Medical Centre Ljubljana
Conditions:
Atherosclerosis
Eligibility:
MALE
40-55 years
Phase:
NA
Brief Summary
The study was designed to test whether short-term treatment with a very low-dose combination of fluvastatin and valsartan could induce improvement of endothelial function, arterial stiffness, vascular...
Detailed Description
The largest population that suffers from cardiovascular events are subjects at moderate cardiovascular risk. However, no effective and safe preventive treatment is available for this population. This ...
Eligibility Criteria
Inclusion
- moderate cardiovascular risk according to Systematic Coronary Risk Estimation (SCORE) risk charts of the European Society of Cardiology
- males
- aged between 40 and 55 years
Exclusion
- diabetes mellitus
- manifest peripheral artery disease or carotid artery disease
- acute infection
- chronic diseases
- present therapy with fluvastatin and/or valsartan
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2017
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03393377
Start Date
September 1 2014
End Date
June 1 2017
Last Update
January 8 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.